HawsGoodwin Investment Management’s Merck MRK Stock Holding History

HawsGoodwin Investment Management’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	$1.01M	Sell	13,180 -234	-2%	-$18.6K	0.29%	70
2021 Q3	$1.01M	Buy	13,414 +387	+3%	+$29.4K	0.31%	70
2021 Q2	$1.01M	Sell	13,027 -551	-4%	-$41K	0.31%	68
2021 Q1	$999K	Sell	13,578 -1,801	-12%	-$133K	0.32%	66
2020 Q4	$1.2M	Buy	15,379 +1,428	+10%	+$109K	0.38%	61
2020 Q3	$1.1M	Buy	13,951 +16	+0.1%	+$1.25K	0.39%	56
2020 Q2	$1.03M	Sell	13,935 -1,868	-12%	-$141K	0.4%	57
2020 Q1	$1.16M	Sell	15,803 -1,620	-9%	-$127K	0.58%	51
2019 Q4	$1.51M	Buy	+17,423	New	+$1.43M	0.79%	51

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HawsGoodwin Investment Management's MRK Position: Q4 2021 in Review

HawsGoodwin Investment Management reduced its Merck (MRK) stake by 1.7% in Q4 2021, selling an estimated $18.6K and leaving 13,180 shares worth $1.01M. The position accounts for 0.29% of the portfolio, ranked #70.

HawsGoodwin Investment Management first reported a position in MRK in Q4 2019 and has held it in 9 quarters since. The position peaked at $1.51M in Q4 2019. 2,902 funds tracked by Wall St. Rank hold MRK as of Q4 2021.

HawsGoodwin Investment Management held 13,180 shares of Merck worth $1.01M as of Q4 2021.
HawsGoodwin Investment Management sold 234 Merck shares in Q4 2021, an estimated $18.6K.
Merck made up 0.29% of HawsGoodwin Investment Management's portfolio in Q4 2021, its #70 holding.
HawsGoodwin Investment Management first reported a position in Merck in Q4 2019 and has held it in 9 quarters since.
HawsGoodwin Investment Management's Merck position peaked at $1.51M in Q4 2019.
2,902 funds tracked by Wall St. Rank held Merck as of Q4 2021.

Based on HawsGoodwin Investment Management's 13F filing for Q4 2021, filed 9 Feb 2022.